| Hazard Information | Back Directory | [Uses]
Monoclonal antibody (antiviral). | [in vivo]
Tuvirumab (OST 577; SDZ-OST 577; 5 mg/kg; iv; single dose) followed by intravenous wild-type HBV, the MS-2 strain, directs against the a determinant of HBV surface antigen delayed but does not prevent experimental infection of HBV and hepatitis in the chimpanzee[1].
Tuvirumab (5 mg/kg; iv) has a half-life of 16.7 days in the chimpanzee[1].
|
|
| Company Name: |
Cell Sciences
|
| Tel: |
9785721070 |
| Website: |
www.cellsciences.com |
|